Bcl-2 and Bcl-xL suppress glucose signaling in pancreatic β-cells

Area of Science:

• Cell Biology
• Endocrinology
• Metabolism

Background:

• B-cell lymphoma 2 (Bcl-2) family proteins are key regulators of apoptosis.
• Their role in normal primary cell function, particularly pancreatic beta-cells, is emerging.
• Understanding these roles is crucial for metabolic disease research.

Purpose of the Study:

• To investigate the impact of inhibiting antiapoptotic Bcl-2 and Bcl-x(L) on pancreatic beta-cell function.
• To determine if Bcl-2 family proteins modulate glucose-dependent signaling and insulin secretion.
• To explore the physiological relevance of Bcl-2 proteins in beta-cell glucose metabolism.

Main Methods:

• Utilized chemical antagonism and genetic knockout (Bcl-2(-/-), Bax-Bak knockout, inducible Bcl-x(L) deletion) in mouse models.
• Measured metabolic signals (NAD(P)H), Ca(2+) flux, mitochondrial membrane potential, and insulin secretion.
• Assessed in vivo glucose tolerance in conditional knockout mice.

Main Results:

• Chemical and genetic inhibition of Bcl-2/Bcl-x(L) augmented glucose-dependent Ca(2+) signals and insulin release.
• Loss of Bcl-2 or Bcl-x(L) enhanced beta-cell responses to glucose independently of Bax-Bak.
• Mice lacking Bcl-2 or with inducible Bcl-x(L) deletion showed improved glucose tolerance.

Conclusions:

• Prosurvival Bcl-2 proteins normally dampen pancreatic beta-cell responses to glucose.
• Bcl-2 family members act as integrators of cell death pathways and beta-cell physiology.
• Targeting Bcl-2 proteins may offer novel therapeutic strategies for metabolic disorders.